home / stock / xbi / xbi news


XBI News and Press, SPDR Series Trust S&P Biotech From 01/23/26

Stock Information

Company Name: SPDR Series Trust S&P Biotech
Stock Symbol: XBI
Market: NYSE

Menu

Get XBI Alerts

News, Short Squeeze, Breakout and More Instantly...

XBI - Investors should be 'cautious' about getting out of this 'rodeo bull' market - Morgan Stanley's Lacamp

2026-01-23 13:50:43 ET More on the markets Oil May Be Heading For A Breakout Markets On Thin Ice: Greenland Framework, Japan's Yield Shock, And A Fragile Tape Trump 2.2: Can The Market Keep Rallying In His Second Year Of Presidency? JPMorgan’s top shor...

XBI - Healthcare debate should focus on out-of-pocket costs, not list prices - Novartis CEO

2026-01-22 13:04:02 ET More on Novartis Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Novartis: A Mispriced Hedge In A Crowded Equity Mark...

XBI - 2025 ETF Wrap-Up And What To Expect In 2026

2026-01-22 07:15:00 ET Typically, the first full blog of the year reviews returns of benchmark index ETFs and opines on what prevailed in the past year through five years, then provides analysis that could provide insights into the future for US equities and other asset classes. This ye...

XBI - Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?

2026-01-22 06:07:00 ET By Vinay Thapar, CFA and Jane Bleeg More clarity on regulatory and policy issues can help healthcare stocks reassert their fundamental strengths. Read the full article on Seeking Alpha For further details see: Are Healthcare Stocks Pois...

XBI - BBH: Mature Biotech Exposure, But Limited Growth Ahead

2026-01-21 16:26:22 ET Investment Thesis Read the full article on Seeking Alpha For further details see: BBH: Mature Biotech Exposure, But Limited Growth Ahead

XBI - U.S. Earnings: Broadening Strength

2026-01-13 06:30:00 ET Transcript We just had three years of double-digit returns for S&P 500 that is quite rare, and if we make it into four depends a lot on earnings. Q4 is starting to report, and there are three themes on my mind.... Read the full article on...

XBI - Biopharma stocks to see increased M&A activity amid Eli Lilly-Ventyx deal

2026-01-08 13:15:11 ET More on biotech, biopharma Biotech: Time For A Pause To Start 2026 2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sec...

XBI - Healthcare Stocks In Focus: Assessing The Outlook For 2026

2026-01-08 05:30:00 ET After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk...

XBI - Leveraged ETF Drift Watch List And Focus On SQQQ

2026-01-02 10:04:54 ET ... Read the full article on Seeking Alpha For further details see: Leveraged ETF Drift Watch List And Focus On SQQQ

XBI - Biotech: Time For A Pause To Start 2026

2026-01-02 06:52:42 ET The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the ad...

Previous 10 Next 10